Announcing TaMADOR: A Collaborative Working Group for Targeted Mass Spectrometry Assays Mike MacCoss  2020-05-08 15:45:26

Two NIDDK programs, one focused on Type 1 Diabetes ( and one focused on Obesity ( are working together to develop and share quantitative protein assays. Andy Hoofnagle's lab at the University of Washington is working on Type 1 Diabetes. Jenny Van Eyk's and Wei-Jun Qian's labs at Cedars-Sinai and PNNL respectively are working on Obesity. To leverage each other's capabilities and strengths we have formed a working group that we call TaMADOR (Targeted Mass Spectrometry Assays for Diabetes and Obesity Research).